Nausea: 3,590 Severe Vomiting: 2,031 Pancreatitis: 607 Abdominal Distension: 555 Abdominal Pain: 548 Abdominal/Stomach Pain: 512 Gastroesophageal Reflux Disease: 274 Gastrointestinal Disorder: 240 Acute Kidney Injury: 196 Cholelithiasis: 119 Renal Failure: 92 Impaired Gastric Emptying: 82 Gastric Disorder: 65 Gastritis: 60 Gallbladder Disorder: 48 Gastroenteritis: 31 Ozempic Warning Label Failures Despite thousands of adverse reactions being reported by individuals taking Ozempic within the first several years of being on the market, the manufacturer failed to issue a timely warning
The relationship between berberine and constipation is complex and somewhat paradoxical
GLP-1 At the end of 2014, liraglutide 3mg became the first GLP1R agonist approved for the treatment of obesity, which is approximately twice the highest dose used in T2D therapy
The outcome will directly impact BPC-157 availability
July 24, 2026: Emideltide (DSIP), Semax, and Epitalon
TB-500 also exhibits clinically relevant anti-inflammatory properties through downregulation of inflammatory cytokines including TNF- and IL-1
